264 filings
Page 7 of 14
4
31955wba0utg5sw
5 May 21
Eton Pharmaceuticals / William Wilson Troutman ownership change
4:15pm
4
5ap65n
5 May 21
Eton Pharmaceuticals / Jennifer McKie Adams ownership change
4:15pm
4
gwg1lc9yb
5 May 21
Eton Pharmaceuticals / PAUL V MAIER ownership change
4:15pm
8-K
clfx5n0s
13 Apr 21
Other Events
5:00pm
4
rz86h86
12 Apr 21
Change in insider ownership
7:55pm
424B3
53yso id9hwwxh6ubtc
9 Apr 21
Prospectus supplement
7:00am
8-K
sjg840faxc7
8 Apr 21
Other Events
8:05am
424B3
aj8jl7
7 Apr 21
Prospectus supplement
4:06pm
3
rtuad6 a0cgo
17 Mar 21
Eton Pharmaceuticals / Jennifer McKie Adams ownership change
4:31pm
8-K
y9xjikfrhmwg
17 Mar 21
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
4:28pm
8-K
m52pr3s
16 Mar 21
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
4:48pm
8-K
3t3m7skwd
24 Feb 21
Other Events
4:54pm
SC 13G/A
dtsv3i m5
16 Feb 21
Eton Pharmaceuticals / APPEL PETER A ownership change
5:02pm
5
9soy4ax4 fxoc
16 Feb 21
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
8:59am
8-K
sdyyil70 4c45
8 Feb 21
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
8:50am
8-K
dr2hybmt8g2tvd5f
14 Jan 21
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDIĀ® SPRINKLE
9:28am
8-K
zly1vdz 1w
17 Dec 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
9:17am
8-K
m1wt iiros
24 Nov 20
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDIĀ® SPRINKLE (hydrocortisone) in the United States
4:38pm